Otsuka Medical Devices Co., Ltd., a fully owned subsidiary of Otsuka Holdings Co., Ltd., and its subsidiary ReCor Medical, Inc. announced the presentation of 6-month results from the RADIANCE-HTN TRIO study, a randomized sham-controlled trial in patients with resistant hypertension.
PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.

Source: https://www.biospace.com/article/releases/recor-medical-reports-latest-data-from-landmark-renal-denervation-clinical-trials-at-tct-annual-meeting/?s=93